Follicular mucinosis associated with imatinib (STI571)

被引：13
|
作者：
Yanagi, T [1 ]
Sawamura, D [1 ]
Shimizu, H [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2004年 / 151卷 / 06期
关键词：
D O I：
10.1111/j.1365-2133.2004.06295.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1276 / 1278
页数：5
相关论文
共 50 条
  • [1] Pharmacology of imatinib (STI571)
    Buchdunger, E
    O'Reilly, T
    Wood, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S28 - S36
  • [2] Pityriasis rosea associated with imatinib (STI571,Gleevec)
    Konstantopoulos, K
    Papadogianni, A
    Dimopoulou, M
    Kourelis, C
    Meletis, J
    [J]. DERMATOLOGY, 2002, 205 (02) : 172 - 173
  • [3] RNAi meets imatinib mesylate (STI571)
    Eder, M
    Scherr, M
    [J]. BLOOD, 2003, 102 (06) : 1942 - 1942
  • [4] STI571 (imatinib mesylate): the tale of a targeted therapy
    Thambi, P
    Sausville, EA
    [J]. ANTI-CANCER DRUGS, 2002, 13 (02) : 111 - 114
  • [5] Inhibition of multiple myeloma proliferation by imatinib mesylate (STI571).
    Pandiella, A
    Carvajal, X
    Tabera, S
    Mateo, G
    San Miguel, JF
    [J]. BLOOD, 2002, 100 (11) : 601A - 601A
  • [6] Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
    A Hochhaus
    S Kreil
    AS Corbin
    P La Rosée
    MC Müller
    T Lahaye
    B Hanfstein
    C Schoch
    NCP Cross
    U Berger
    H Gschaidmeier
    BJ Druker
    R Hehlmann
    [J]. Leukemia, 2002, 16 : 2190 - 2196
  • [7] Selective tyrosinekinase inhibitor imatinib (STI571) in haematological and oncological disease
    Hochhaus, A
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (09) : 451 - 456
  • [8] Combination therapy with imatinib mesylate (STI571):: Synopsis of in vitro studies
    Topaly, J
    Zeller, WJ
    Fruehauf, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) : 3 - 14
  • [9] Imatinib mesylate (STI571) for myeloid malignancies other than CML
    Krystal, GW
    [J]. LEUKEMIA RESEARCH, 2004, 28 : S53 - S59
  • [10] Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
    Renaud Capdeville
    Elisabeth Buchdunger
    Juerg Zimmermann
    Alex Matter
    [J]. Nature Reviews Drug Discovery, 2002, 1 : 493 - 502
12345